首页> 外文OA文献 >Molecular subtypes of systemic sclerosis in association with anti-centromere antibodies and digital ulcers
【2h】

Molecular subtypes of systemic sclerosis in association with anti-centromere antibodies and digital ulcers

机译:系统性硬化症的分子亚型与抗着丝粒抗体和数字溃疡相关

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The objective of this study was to identify molecular profiles that may distinguish clinical subtypes in systemic sclerosis (SSc). Large-scale gene expression profiling was performed on peripheral blood (PB) from 12 SSc patients and 6 healthy individuals. Significance analysis of microarrays, two-way hierarchical cluster analysis and PANTHER (Protein ANalysis THrough Evolutionary Relationships) ontology classification were used to analyze the data. Quantitative PCR was applied for validation in a cohort of 43 SSc patients. The results show that the expression of genes involved in immune defense, cell cycle and signal transduction was significantly elevated in PB of SSc patients (n=12) compared with healthy individuals (n=6). SSc patients could be stratified into subgroups based on differential expression of genes induced by type I interferon (IFN) and genes involved in antimicrobial (AM) activity. Differential expression of type I IFN or AM signature genes was validated and extended in an independent cohort of 31 patients by quantitative PCR. Low expression of IFN response genes was associated with the presence of anti-centromere antibodies, whereas increased expression was associated with the appearance of digital ulcers. In conclusion, patients with SSc can be classified on the basis of differential expression of immune defense genes. Differences in the activity of the type I IFN response program stratify patients into two clinically relevant subgroups
机译:这项研究的目的是确定可以区分系统性硬化症(SSc)临床亚型的分子特征。对12名SSc患者和6名健康个体的外周血(PB)进行了大规模的基因表达谱分析。使用微阵列的重要性分析,双向层次聚类分析和PANTHER(蛋白质分析通过进化关系)本体分类来分析数据。定量PCR被用于43例SSc患者的验证。结果表明,与健康个体(n = 6)相比,SSc患者(n = 12)的PB中涉及免疫防御,细胞周期和信号转导的基因表达显着升高。根据由I型干扰素(IFN)诱导的基因和涉及抗菌(AM)活性的基因的差异表达,SSc患者可分为亚组。通过定量PCR在31例患者的独立队列中验证并扩展了I型IFN或AM签名基因的差异表达。 IFN应答基因的低表达与抗着丝粒抗体的存在有关,而表达增加与数字溃疡的出现有关。总之,SSc患者可以根据免疫防御基因的差异表达进行分类。 I型IFN反应程序活性的差异将患者分为两个临床相关的亚组

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号